PMID: 16502751Mar 1, 2006Paper

How relevant are exercise capacity measures for evaluating treatment effects in chronic fatigue syndrome? Results from a prospective, multidisciplinary outcome study

Clinical Rehabilitation
K PardaensB Van Houdenhove

Abstract

To evaluate the outcome of a multidisciplinary treatment programme for patients with chronic fatigue syndrome, including health-related quality of life (HRQoL) and psychosocial variables, and exercise capacity measures. A six-month prospective outcome study. University outpatient rehabilitation clinic; group setting. One hundred and sixteen women fulfilling chronic fatigue syndrome criteria. Cognitive behaviourally and graded exercise-based strategies; emphasis on adaptive lifestyle changes. Short Form General Health Survey (SF-36); Symptom Checklist (SCL-90); Causal Attribution List (CAL); Self-Efficacy Scale (SE); maximum progressive bicycle ergometer test with respiratory gas analysis; and isokinetic leg strength test, before and after treatment. The total group significantly improved on nearly all reported HRQoL/psychosocial variables. Changes in exercise capacity measures were rather modest and did not correlate or only weakly correlated with HRQoL/psychosocial variables. Subgroup analyses indicated that less fit patients improved significantly more on exercise capacity measures than their more fit counterparts. Patients who were fitter at baseline scored better on pretreatment HRQoL/psychosocial variables, but both subgro...Continue Reading

References

Jun 7, 1997·BMJ : British Medical Journal·K Y Fulcher, P D White
Nov 3, 1998·QJM : Monthly Journal of the Association of Physicians·F De LorenzoV V Kakkar
Nov 26, 1998·The British Journal of Psychiatry : the Journal of Mental Science·A J WeardenJ A Morris
May 5, 2000·The Cochrane Database of Systematic Reviews·B H RoweC A Camargo
Aug 17, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·K Y Fulcher, P D White
Jan 11, 2001·Neuropsychobiology·J E OttenwellerB H Natelson
Feb 13, 2001·Journal of Psychosomatic Research·P D White
Feb 13, 2001·Journal of Psychosomatic Research·S P van der WerfG Bleijenberg
Sep 19, 2001·JAMA : the Journal of the American Medical Association·P WhitingG Ramírez
Feb 4, 2003·The American Journal of Psychiatry·Niloofar Afari, Dedra Buchwald
Mar 12, 2003·Journal of Behavior Therapy and Experimental Psychiatry·Fred Friedberg
Apr 24, 2003·Clinical Science·Evelina GeorgiadesYannis P Pitsiladis
Jun 5, 2003·Medicine and Science in Sports and Exercise·J Mark VannessStaci R Stevens
Feb 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Pauline PowellRichard H T Edwards
Feb 7, 2004·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·Renée R Taylor
Mar 16, 2004·Journal of Psychosomatic Research·M M AndersenF Albrecht
Mar 24, 2004·Trends in Endocrinology and Metabolism : TEM·Anthony J Cleare
Apr 30, 2004·The Medical Journal of Australia·Andrew R Lloyd
Apr 30, 2004·The Medical Journal of Australia·Karen E WallmanAndrew M Guilfoyle
May 26, 2004·Archives of Internal Medicine·Susan D RossCindy B Levine
Jun 24, 2004·Archives of Disease in Childhood·R VinerS El Neil
Jul 22, 2004·The Cochrane Database of Systematic Reviews·M EdmondsJ Price
Aug 5, 2004·Psychotherapy and Psychosomatics·Boudewijn Van Houdenhove, Ulrich T Egle
Oct 7, 2004·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·M L SchillingsM J Zwarts
Dec 15, 2004·Medicine and Science in Sports and Exercise·Karen E WallmanRobert Grove
Feb 23, 2005·Journal of Health Psychology·Rona Moss-MorrisJames C Baldi
Jun 1, 2005·Journal of Affective Disorders·W K JerjesN F Taylor

❮ Previous
Next ❯

Citations

Jan 6, 2009·Psychosomatics·Boudewijn Van Houdenhove, Patrick Luyten
Jun 26, 2012·European Journal of Clinical Investigation·Deborah Van CauwenberghJo Nijs
Sep 24, 2009·Patient Education and Counseling·Boudewijn Van Houdenhove, Patrick Luyten
Aug 17, 2011·Journal of Psychosomatic Research·Richard M H EveringMiriam M R Vollenbroek-Hutten
Feb 20, 2010·Journal of Affective Disorders·Stefan KempkePeter Van Wambeke
Nov 29, 2007·Clinical Rehabilitation·C AyánM J Barrientos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.